Hjem › Graves sygdom › Florida
Graves sygdom kliniske forsøg i Florida
8 studier for Graves sygdom søger deltagere på steder i Florida.
Byer i Florida
Officiel studietekst (engelsk)
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
- DM Clinical Research, Doral
- Floridian Clinical Research - Clinitiative, Miami
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07722546Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
- Site-052, Doral
- Site-066, Fort Myers
- Site-019, Hialeah
- og 4 flere
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 1. okt. 2026 · NCT07661056NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
- Site # 1101, Hollywood
- Site # 1112, Miami
- Site # 1109, Wesley Chapel
RekruttererFase 1
Alder 18 til 65 · Alle køn · Opdateret 30. sep. 2026 · NCT07305818A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
- Northeast Florida Endocrine & Diabetes Associates (NEFEDA) - Orange Park Location, Fleming Island
- The Center for Diabetes and Endocrine Care, Fort Lauderdale
- University of Florida Jacksonville College of Medicine, Jacksonville
- og 2 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07570316Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
- Site 109, Miami Lakes
- Site 115, Palm Harbor
- Site 123, Sarasota
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07682896A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1024, Doral
- Site Number - 1008, Hialeah
- Site Number - 1000, Miami
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 25. aug. 2026 · NCT07018323A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1029, Clearwater
- Site Number - 1055, Jacksonville
- Site Number - 1056, Jacksonville
- og 4 flere
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 25. aug. 2026 · NCT06727604Study of BHV-1300 in Graves' Disease
- Site-100, Miami
RekruttererFase 1
Alder 18 til 65 · Alle køn · Opdateret 31. jul. 2026 · NCT06980649Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.